These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors. Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053 [TBL] [Abstract][Full Text] [Related]
3. Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions. Abedi A; Sizdahkhani S; Choi W; Nguyen VN; Rennert RC; Russin JJ Neurosurg Focus; 2023 Oct; 55(4):E9. PubMed ID: 37778042 [TBL] [Abstract][Full Text] [Related]
4. Ameliorative Effects of Combined Revascularization Surgery on Abnormal Collateral Channels in Moyamoya Disease. Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Kuroda S J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105624. PubMed ID: 33516067 [TBL] [Abstract][Full Text] [Related]
5. Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis. Liu T; Qin M; Xiong X; Li T; Feng L; Lai X; Gao Y Front Neurol; 2023; 14():1132339. PubMed ID: 37409015 [TBL] [Abstract][Full Text] [Related]
6. Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports. Koh MY; Toh KZ; Ho JS; Yeo LL; Ho AF; Sia CH; Tan BY J Thromb Thrombolysis; 2022 Aug; 54(2):339-349. PubMed ID: 35699873 [TBL] [Abstract][Full Text] [Related]
7. The natural clinical course of hemodynamically stable adult moyamoya disease. Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479 [TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study. Luo Y; Cao Z; Ye H; Wu S; Sun X J Neurol; 2023 Aug; 270(8):3876-3884. PubMed ID: 37106259 [TBL] [Abstract][Full Text] [Related]
9. Adult Moyamoya Disease and Moyamoya Syndrome: What Is New? Uchiyama S; Fujimura M Cerebrovasc Dis Extra; 2024; 14(1):86-94. PubMed ID: 39043157 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of Bypass Surgery in Adult Moyamoya Disease by Onset Type. Lim YC; Lee E; Song J JAMA Netw Open; 2024 Jun; 7(6):e2415102. PubMed ID: 38842810 [TBL] [Abstract][Full Text] [Related]
11. Risk profile in extracranial/intracranial bypass surgery--the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures. Schubert GA; Biermann P; Weiss C; Seiz M; Vajkoczy P; Schmiedek P; Thomé C World Neurosurg; 2014 Nov; 82(5):672-7. PubMed ID: 23838364 [TBL] [Abstract][Full Text] [Related]
12. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597 [TBL] [Abstract][Full Text] [Related]
13. Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan. Yamada S; Oki K; Itoh Y; Kuroda S; Houkin K; Tominaga T; Miyamoto S; Hashimoto N; Suzuki N; J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):340-9. PubMed ID: 26654669 [TBL] [Abstract][Full Text] [Related]
14. Postoperative Functional Outcomes and Prognostic Factors in Two Types of Adult Moyamoya Diseases. Zhang M; Tang J; Liu N; Xue Y; Ren X; Fu J J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104846. PubMed ID: 32439351 [TBL] [Abstract][Full Text] [Related]
15. Natural course of hemodynamically stable hemispheres contralateral to operated hemispheres in adult patients with ischemic moyamoya diseases. Kang YS; Cho WS; Nam SM; Chung Y; Lee SH; Kim K; Kang HS; Kim JE Sci Rep; 2024 Apr; 14(1):8358. PubMed ID: 38600292 [TBL] [Abstract][Full Text] [Related]
16. Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study. Seo WK; Kim JY; Choi EH; Kim YS; Chung JW; Saver JL; Bang OY; Kim GM J Am Heart Assoc; 2021 Feb; 10(5):e017701. PubMed ID: 33615836 [TBL] [Abstract][Full Text] [Related]
17. Clinical course of asymptomatic adult moyamoya disease. Jo KI; Yeon JY; Hong SC; Kim JS Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort. Chiba T; Setta K; Shimada Y; Yoshida J; Fujimoto K; Tsutsui S; Yoshida K; Kobayashi M; Kubo Y; Fujiwara S; Terasaki K; Ogasawara K J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3373-3379. PubMed ID: 30174225 [TBL] [Abstract][Full Text] [Related]
19. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267 [TBL] [Abstract][Full Text] [Related]
20. Incidence, prevalence, and treatment of Moyamoya disease in Japan: A population-based descriptive study. Liu H; Fukasawa T; Anno T; Takeuchi M; Shimazaki S; Yang T; Kawakami K J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107770. PubMed ID: 38768667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]